Literature DB >> 24980905

Sudden and isolated Broca's aphasia: a new clinical phenotype of anti NMDA receptor antibodies encephalitis in children.

Kumaran Deiva1, Maria Carmela Pera2, Hélène Maurey2, Pascale Chrétien3, Frédérique Archambaud4, Viviane Bouilleret5, Marc Tardieu6.   

Abstract

BACKGROUND: Anti NMDA receptor (anti NMDAR) encephalitis is a well-characterized entity in children associating movement disorders, psychiatric features and speech difficulties. Novel phenotypes have been described in adults. METHODS AND
RESULTS: A 4-year-old girl presented partial seizures which evolved towards sudden and isolated Broca's aphasia. Anti NMDAR antibodies were positive in CSF and serum confirming anti NMDAR encephalitis. Clinical recovery was observed after a specific treatment.
CONCLUSION: This case widens the clinical spectrum of anti-NMDAR encephalitis in children and awareness of this newly identified symptom is important as early treatment is a predictor of good outcome.
Copyright © 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Auto immune; Broca's aphasia; Children; Epilepsy; NMDAR encephalitis

Mesh:

Substances:

Year:  2014        PMID: 24980905     DOI: 10.1016/j.ejpn.2014.06.002

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  2 in total

1.  Anti-NMDA receptor encephalitis presenting as atypical anorexia nervosa: an adolescent case report.

Authors:  David Mechelhoff; Betteke Maria van Noort; Bernhard Weschke; Christian J Bachmann; Christiane Wagner; Ernst Pfeiffer; Sibylle Winter
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-02-08       Impact factor: 4.785

2.  Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report.

Authors:  Chuan-Chen Hu; Xiao-Ling Pan; Mei-Xia Zhang; Hong-Fang Chen
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.